Newsletter | July 23, 2024

07.23.24 -- Beware AI Hallucinations

SPONSOR

Webinar: Innovative AI-Driven Solutions to Address the Growing Complexity of APIs

Discover CASP technologies - the award-winning AI and vast data that propel Lonza’s leading predictive retrosynthesis technology, used to mitigate the impact of rising small mol API complexity and its resulting longer syntheses. Learn how it’s been tailored for Preclinical Route Design, and impacted synthetic route brevity, supply chain strategy and route selection as part of their Lonza AI-Enabled Route Scouting Service. Click here.

FEATURED EDITORIAL

Beware AI Hallucinations

As the use of AI increases and expands to new functional areas within biopharmaceutical companies, leaders must understand the risks and mitigate the impact of hallucinations in AI model outputs.

INDUSTRY INSIGHTS

Driving Sustainability In Spray Drying Through Enabling Technologies

By transitioning to alternative solvents or leveraging process aids, the challenges associated with the use of these chemicals can be addressed, helping create a sustainable, greener footprint.

Drug Discovery And Screening, A Digital Era For RNA-LNP Therapeutics

Learn about the key stages of drug discovery and screening as well as how to overcome bottlenecks in screening mRNA-LNPs to rapidly develop genomic medicines.

Getting CMC Right For Emerging Technologies

Establishing a chemistry, manufacturing, and controls strategy that proves a clinical program is tightly controlled and can address risk is critical to avoiding the pitfalls that stall many promising therapeutics.

Implement Solvent Recycling To Reduce Waste And CO2 Emissions

Creating a greener manufacturing platform that accommodates solvent recovery and recycling requires careful consideration of your resources, procedures, and partnerships to achieve cost-effective goals.

SPONSOR

Explore the forefront of precision medicine at the Advancing Precision Medicine Conference and Exhibition in Philadelphia, November 1-2. Engage with cutting-edge research featuring experts who are shaping the future of healthcare. Discover new insights into personalized treatments, genomic advancements, and innovative technologies revolutionizing patient care. Expand your knowledge and network with leaders driving the field forward. View the agenda and register today!

MOST POPULAR NEWS

Genomics Plc Announces A 3-Year Extension Of The Company's Collaboration With Vertex

Breakthrough In High-Perf Computing & Quantum Chemistry Revolutionizes Drug Discovery

Sanyou Bio Collaborates On ADC Drug Development Entering Phase I Clinical Trials

Light-Activated Drugs Against Neuropathic Pain

Ipsen & Foreseen Announce Exclusive Global Licensing Agreement For ADC

SOTIO Enters Into Multi-Target Antibody Agreement With Biocytogen To Expand ADC Pipeline

NexThera Files IND Application For Phase 1/2a Clinical Trial Of NT-101 Eye Drop For Wet AMD

Eton Pharmaceuticals Announces FDA Acceptance Of NDA For ET-400

A Comprehensive Derivative Synthesis Method For Development Of New Antimicrobial Drugs

Modular Assembly Of Ethylene, Arenes And Heteroarenes

Junshi Biosciences Announces The Acceptance Of The sNDA For Toripalimab Combined With Bevacizumab

SOLUTIONS

Continuous Flow

Affinity Chromatography Resin For Purifying Recombinant Proteins